Buttigieg Says Medical Marijuana Has Helped Veterans, His Family

Photo by Tianlei Wu via Unsplash.

Pete Buttigieg wasn't in Nebraska to talk about cannabis. He was there to campaign for a Democratic congressional candidate, in the kind of low-profile swing-state stop that's become a ritual for politicians widely believed to be eyeing a 2028 presidential run. But when the subject of medical marijuana came up, Buttigieg didn't dodge it. He talked about veterans he served with, about extended family members, and about what he sees as a plainly obvious policy consensus that Washington still hasn't caught up to.

The timing is what makes the remarks worth more than a passing mention. Nebraska voters approved medical cannabis at the ballot box in 2024, and the state is only now, deep into 2026, working through the mechanics of actually standing up a functioning program. Buttigieg's comments landed right in the middle of that slow-motion rollout, giving his personal remarks an unusually concrete backdrop rather than the abstract policy talk that usually surrounds these moments.

What Buttigieg Actually Said

Photo by Mikhail Nilov via Pexels.

Buttigieg's comments came during a stop in Lincoln, where he appeared alongside Denise Powell, the longtime organizer behind Nebraska's medical cannabis ballot campaign. Asked about the issue, he didn't hedge. He said access to medical cannabis has certainly made a difference to people he served with, to people in his extended family, and that he hopes common sense prevails going forward. It's a notably personal framing for a politician who has mostly discussed cannabis policy in wonkier terms tied to his old cabinet post.

He also made a broader claim about public opinion, saying he believes the American majority already recognizes that people should have access to medical cannabis when they need it. That's consistent with years of polling showing overwhelming, often bipartisan, support for medical marijuana access specifically, even in states where recreational legalization remains a harder sell.

According to a report from Nebraska.tv, Buttigieg was candid about the limits of his own knowledge here, acknowledging he wasn't deeply versed in the specifics of Nebraska's rollout, its licensing structure, or its timeline. What he emphasized instead was the underlying sentiment: that regardless of the bureaucratic details in any particular state, he believes the case for allowing sick people access to a treatment that has helped people close to him is not seriously in dispute among most voters.

Nebraska's Medical Cannabis Program Is Still Taking Shape

Photo by Markus Winkler via Pexels.

Nebraska's medical cannabis program exists because voters put it there directly. In November 2024, the state's ballot initiatives passed with wide margins, legalizing medical cannabis possession and setting up a framework for a regulated supply chain. Since then, Gov. Jim Pillen has signed permanent regulations governing how the program will actually operate, and the Nebraska Medical Cannabis Commission held its first meeting under those rules on July 20, 2026, nearly two years after voters weighed in.

The fee structure gives a sense of what it will take to get into this market. Applicants face a $5,000 application fee across the board, with cultivators and manufacturers paying $20,000, dispensaries paying $15,000, and transporters paying $10,000. Those aren't small numbers for a program still working out basic logistics, and they've shaped who's able to even apply in the first place.

That reality showed up almost immediately. The commission extended its manufacturing application deadline from July 20 to Aug. 17, citing an insufficient number of applications to move forward as originally planned. Advocate Crista Eggers, who has been a visible presence in Nebraska's cannabis reform push, used the commission's meeting to press regulators to move faster and to add explicit legal protections for physicians willing to recommend medical cannabis to patients.

Dispensary applications are expected to open around Aug. 15, with regulators floating the possibility that actual sales could begin by December 2026. Even that estimate came with caveats from officials, who acknowledged further delays are entirely possible given how the process has gone so far.

Not a New Position for Buttigieg

Photo by Vitaly Gariev via Unsplash.

Buttigieg's Nebraska comments aren't a new political posture manufactured for a possible 2028 run. Back in October 2019, while running for president the first time, he visited a Las Vegas dispensary and told Marijuana Moment that VA doctors should be permitted to recommend medical cannabis to veterans, a position that put him ahead of where federal policy still stands today. He also argued at the time that legitimate medical cannabis use ought to be covered by health insurance, treating it as a medical question rather than a criminal justice one.

As a 2020 candidate, he went further than incremental fixes, endorsing full legalization of cannabis along with broader decriminalization of drugs more generally. That platform included expungement of past cannabis convictions, framed explicitly as part of a racial justice agenda given how drug enforcement has disproportionately affected Black and Latino communities for decades.

His record since then has been more constrained by the job he actually held. As Transportation Secretary in 2024, Buttigieg told Congress that rescheduling cannabis to Schedule III wouldn't change drug testing requirements for commercial truck drivers, since the Department of Transportation maintains its own specific screening protocol for marijuana separate from the DEA's scheduling categories. It was a technical, careful answer from a cabinet official bound by federal rules, a contrast with the freer, more personal remarks he's able to make now as a private citizen campaigning around the country.

Why the Timing Matters

Photo by Joshi Milestoner via Unsplash.

Buttigieg's remarks carry extra weight because of where he sits politically. As one of the more frequently mentioned potential Democratic contenders for 2028, essentially everything he says on a campaign trip gets read partly as positioning. Whether or not that's fair, it means his comfort talking openly about cannabis and veterans signals where he thinks the party's coalition already stands on the issue.

Nebraska's situation also matters because it's increasingly the exception rather than the rule. Most states that have approved medical cannabis through ballot measures now have functioning markets; Nebraska, despite clear voter approval in 2024, is one of a shrinking number of states still working through licensing and regulation years later. That gap between a yes vote and an actual dispensary shelf is the story here as much as anything Buttigieg said.

All of this is unfolding while a federal rescheduling review of cannabis continues to move, on its own separate and slower timeline, alongside dozens of individual state rollouts that don't sync up with each other at all. Cannabis remains a Schedule I substance under federal law, which means veterans, patients, and caregivers face wildly different levels of access depending entirely on which state they happen to live in.

None of this is uniform, and readers shouldn't assume Nebraska's licensing fees, timelines, or rules say anything about their own state's program. Medical cannabis law varies significantly by state, and anyone trying to access it, or considering entering the industry, should confirm the specific rules where they actually live rather than extrapolate from headlines out of Lincoln or anywhere else.

None of what Buttigieg said in Lincoln reads like a calculated pivot. It's the same position he's held since at least 2019, back when he was a long-shot presidential candidate visiting a Nevada dispensary and arguing VA doctors should be able to recommend cannabis to veterans. The consistency is arguably more notable than the comments themselves, especially from a politician who spent the last several years constrained by a cabinet job that required careful, technical answers rather than personal ones.

Nebraska's own experience is the more instructive part of this story. Voters said yes in 2024. Nearly two years later, the state is still writing rules, extending deadlines, and setting licensing fees that applicants are struggling to meet on schedule. Sales that regulators once hoped to have running by now might not start until the end of 2026, and even that estimate comes with an asterisk from the officials who set it.

That lag between what voters approve and what patients can actually access isn't unique to Nebraska. It's a pattern that's repeated itself in state after state, and there's little reason to think it stops here. Public opinion on medical cannabis access has been settled for years; the machinery of standing up a regulated market clearly hasn't caught up, and probably won't anytime soon.